An immunogenic peptide in the A-box of HMGB1 protein reverses apoptosis-induced tolerance through RAGE receptor

Journal of Biological Chemistry

Volumn 289, Issue 11, 2014, Pages 7777-7786

  LeBlanc, Philippe M ^a   Doggett, Teresa Ann ^b   Choi, Jayoung ^b   Hancock, Mark A ^a   Durocher, Yves ^c   Frank, Filipp ^a   Nagar, Bhushan ^a   Ferguson, Thomas A ^b   Saleh, Maya ^a  

^a MCGILL UNIVERSITY   (Canada)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; BIOLOGY;

ADVANCED GLYCATION END PRODUCTS; APOPTOTIC CELLS; CRITICALLY ILLS; DNA BINDING DOMAIN; HIGH-MOBILITY GROUPS; IMMUNE TOLERANCES; INFLAMMATORY DISEASE; NOSOCOMIAL INFECTION;

CELL DEATH;

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; ASPARTIC ACID; CRYOPYRIN; DENDRITIC CELL VACCINE; HIGH MOBILITY GROUP B1 PROTEIN; INFLAMMASOME; INTERLEUKIN 1BETA CONVERTING ENZYME; RECOMBINANT ENZYME;

A BOX; ACTIVE IMMUNIZATION; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANDIDEMIA; CELL THERAPY; DELAYED HYPERSENSITIVITY; DENDRITIC CELL; DNA BINDING MOTIF; EMBRYO; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IN VITRO STUDY; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; SECONDARY INFECTION; SEPSIS;

APOPTOSIS; CASPASE; INFLAMMATION; INNATE IMMUNITY; RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS (RAGE); SEPSIS; TOLERANCE;

ANIMALS; APOPTOSIS; CANDIDA; CANDIDIASIS; CASPASE 1; DENDRITIC CELLS; FIBROBLASTS; HMGB1 PROTEIN; IMMUNE TOLERANCE; IMMUNITY, INNATE; INFLAMMATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PEPTIDES; RECEPTORS, IMMUNOLOGIC; RECOMBINANT PROTEINS; SEPSIS; SURFACE PLASMON RESONANCE;

EID: 84896307863     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.541474     Document Type: Article

References (38)

1. Martin, G. S., Mannino, D. M., Eaton, S., and Moss, M. (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 348, 1546-1554 (Pubitemid 36437931)
2. Hotchkiss, R. S., and Nicholson, D. W. (2006) Apoptosis and caspases regulate death and inflammation in sepsis. Nat. Rev. Immunol. 6, 813-822 (Pubitemid 44631650)
3. Ayala, A., Herdon, C. D., Lehman, D. L., Ayala, C. A., and Chaudry, I. H. (1996) Differential induction of apoptosis in lymphoid tissues during sepsis: variation in onset, frequency, and the nature of the mediators. Blood 87, 4261-4275 (Pubitemid 26152269)
4. Efron, P. A., Tinsley, K., Minnich, D. J., Monterroso, V., Wagner, J., Lainée, P., Lorré, K., Swanson, P. E., Hotchkiss, R., and Moldawer, L. L. (2004) Increased lymphoid tissue apoptosis in baboons with bacteremic shock. Shock 21, 566-571
5. Lu, M. C., Liu, T. A., Lee, M. R., Lin, L., and Chang, W. C. (2002) Apoptosis contributes to the decrement in numbers of alveolar macrophages from rats with polymicrobial sepsis. J. Microbiol. Immunol. Infect. 35, 71-77 (Pubitemid 34665675)
6. Chung, C. S., Song, G. Y., Lomas, J., Simms, H. H., Chaudry, I. H., and Ayala, A. (2003) Inhibition of Fas/Fas ligand signaling improves septic survival: differential effects on macrophage apoptotic and functional capacity. J. Leukoc. Biol. 74, 344-351 (Pubitemid 38040394)
7. Wesche-Soldato, D. E., Chung, C. S., Lomas-Neira, J., Doughty, L. A., Gregory, S. H., and Ayala, A. (2005) In vivo delivery of caspase-8 or Fas siRNA improves the survival of septic mice. Blood 106, 2295-2301 (Pubitemid 41510799)
8. Schwulst, S. J., Muenzer, J. T., Peck-Palmer, O. M., Chang, K. C., Davis, C. G., McDonough, J. S., Osborne, D. F., Walton, A. H., Unsinger, J., McDunn, J. E., and Hotchkiss, R. S. (2008) Bim siRNA decreases lymphocyte apoptosis and improves survival in sepsis. Shock 30, 127-134
9. Adrie, C., Bachelet, M., Vayssier-Taussat, M., Russo-Marie, F., Bouchaert, I., Adib-Conquy, M., Cavaillon, J. M., Pinsky, M. R., Dhainaut, J. F., and Polla, B. S. (2001) Mitochondrial membrane potential and apoptosis peripheral blood monocytes in severe human sepsis. Am. J. Respir. Crit. Care Med. 164, 389-395 (Pubitemid 32778204)
10. + regulatory T cells through a TRAIL-dependent mechanism. J. Immunol. 184, 6766-6772
11. Meakins, J. L., Christou, N. V., Bohnen, J., and MacLean, L. D. (1982) Failure of delayed hypersensitivity skin testing to predict postoperative sepsis and mortality. Br. Med. J. (Clin. Res. Ed.) 285, 1207-1208
12. Christou, N. V., Meakins, J. L., Gordon, J., Yee, J., Hassan-Zahraee, M., Nohr, C. W., Shizgal, H. M., and MacLean, L. D. (1995) The delayed hypersensitivity response and host resistance in surgical patients. 20 years later. Ann. Surg. 222, 534-546; discussion 546-538
13. Lotze, M. T., and Tracey, K. J. (2005) High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat. Rev. Immunol. 5, 331-342 (Pubitemid 40516158)
14. Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L., Manogue, K. R., Faist, E., Abraham, E., Andersson, J., Andersson, U., Molina, P. E., Abumrad, N. N., Sama, A., and Tracey, K. J. (1999) HMG-1 as a late mediator of endotoxin lethality in mice. Science 285, 248-251 (Pubitemid 29329996)
15. Yang, H., Ochani, M., Li, J., Qiang, X., Tanovic, M., Harris, H. E., Susarla, S. M., Ulloa, L., Wang, H., DiRaimo, R., Czura, C. J., Wang, H., Roth, J., Warren, H. S., Fink, M. P., Fenton, M. J., Andersson, U., and Tracey, K. J. (2004) Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc. Natl. Acad. Sci. U.S.A. 101, 296-301 (Pubitemid 38084244)
16. Li, J., Kokkola, R., Tabibzadeh, S., Yang, R., Ochani, M., Qiang, X., Harris, H. E., Czura, C. J., Wang, H., Ulloa, L., Wang, H., Warren, H. S., Moldawer, L. L., Fink, M. P., Andersson, U., Tracey, K. J., and Yang, H. (2003) Structural basis for the proinflammatory cytokine activity of high mobility group box 1. Mol. Med. 9, 37-45 (Pubitemid 36667690)
17. Andersson, U., Wang, H., Palmblad, K., Aveberger, A. C., Bloom, O., Erlandsson-Harris, H., Janson, A., Kokkola, R., Zhang, M., Yang, H., and Tracey, K. J. (2000) High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J. Exp. Med. 192, 565-570 (Pubitemid 30666257)
18. Tian, J., Avalos, A. M., Mao, S. Y., Chen, B., Senthil, K., Wu, H., Parroche, P., Drabic, S., Golenbock, D., Sirois, C., Hua, J., An, L. L., Audoly, L., La Rosa, G., Bierhaus, A., Naworth, P., Marshak-Rothstein, A., Crow, M. K., Fitzgerald, K. A., Latz, E., Kiener, P. A., and Coyle, A. J. (2007) Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat. Immunol. 8, 487-496 (Pubitemid 46605917)
19. Sha, Y., Zmijewski, J., Xu, Z., and Abraham, E. (2008) HMGB1 develops enhanced proinflammatory activity by binding to cytokines. J. Immunol. 180, 2531-2537
20. Youn, J. H., Oh, Y. J., Kim, E. S., Choi, J. E., and Shin, J. S. (2008) High mobility group box 1 protein binding to lipopolysaccharide facilitates transfer of lipopolysaccharide to CD14 and enhances lipopolysaccharide-mediated TNF-α production in human monocytes. J. Immunol. 180, 5067-5074
21. Hreggvidsdottir, H. S., Ostberg, T., Wähämaa, H., Schierbeck, H., Aveberger, A. C., Klevenvall, L., Palmblad, K., Ottosson, L., Andersson, U., and Harris, H. E. (2009) The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation. J. Leukoc. Biol. 86, 655-662
22. Cassetta, L., Fortunato, O., Adduce, L., Rizzi, C., Hering, J., Rovere-Querini, P., Bianchi, M. E., Alfano, M., and Poli, G. (2009) Extracellular high mobility group box-1 inhibits R5 and X4 HIV-1 strains replication in mononuclear phagocytes without induction of chemokines and cytokines. AIDS 23, 567-577
23. Qin, Y. H., Dai, S. M., Tang, G. S., Zhang, J., Ren, D., Wang, Z. W., and Shen, Q. (2009) HMGB1 enhances the proinflammatory activity of lipopolysaccharide by promoting the phosphorylation of MAPK p38 through receptor for advanced glycation end products. J. Immunol. 183, 6244-6250
24. Tang, D., Kang, R., Zeh, H. J., 3rd, and Lotze, M. T. (2011) High-mobility group box 1, oxidative stress, and disease. Antioxid. Redox Signal. 14, 1315-1335
25. Kazama, H., Ricci, J. E., Herndon, J. M., Hoppe, G., Green, D. R., and Ferguson, T. A. (2008) Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein. Immunity 29, 21-32 (Pubitemid 351952462)
26. Shao, W., Yeretssian, G., Doiron, K., Hussain, S. N., and Saleh, M. (2007) The caspase-1 digestome identifies the glycolysis pathway as a target during infection and septic shock. J. Biol. Chem. 282, 36321-36329
27. Tole, S., Mukovozov, I. M., Huang, Y. W., Magalhaes, M. A., Yan, M., Crow, M. R., Liu, G. Y., Sun, C. X., Durocher, Y., Glogauer, M., and Robinson, L. A. (2009) The axonal repellent, Slit2, inhibits directional migration of circulating neutrophils. J. Leukoc. Biol. 86, 1403-1415
28. Myszka, D. G. (1999) Improving biosensor analysis. J. Mol. Recognit. 12, 279-284
29. Wynn, J. L., Scumpia, P. O., Delano, M. J., O'Malley, K. A., Ungaro, R., Abouhamze, A., and Moldawer, K. L. (2007) Increased mortality and altered immunity in neonatal sepsis produced by generalized peritonitis. Shock 28, 675-683 (Pubitemid 350135472)
30. Kayagaki, N., Warming, S., Lamkanfi, M., Vande Walle, L., Louie, S., Dong, J., Newton, K., Qu, Y., Liu, J., Heldens, S., Zhang, J., Lee, W. P., Roose-Girma, M., and Dixit, V. M. (2011) Non-canonical inflammasome activation targets caspase-11. Nature 479, 117-121
31. Martinon, F., Burns, K., and Tschopp, J. (2002) The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-β. Mol. Cell 10, 417-426 (Pubitemid 35007355)
32. Sparatore, B., Patrone, M., Passalacqua, M., Pedrazzi, M., Gaggero, D., Pontremoli, S., and Melloni, E. (2001) Extracellular processing of amphoterin generates a peptide active on erythroleukaemia cell differentiation. Biochem. J. 357, 569-574 (Pubitemid 32701797)
33. Ito, T., Kawahara, K., Okamoto, K., Yamada, S., Yasuda, M., Imaizumi, H., Nawa, Y., Meng, X., Shrestha, B., Hashiguchi, T., and Maruyama, I. (2008) Proteolytic cleavage of high mobility group box 1 protein by thrombin-thrombomodulin complexes. Arterioscler. Thromb. Vasc. Biol. 28, 1825-1830
34. Hori, O., Brett, J., Slattery, T., Cao, R., Zhang, J., Chen, J. X., Nagashima, M., Lundh, E. R., Vijay, S., Nitecki, D., et al. (1995) The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin: mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J. Biol. Chem. 270, 25752-25761
35. Yanai, H., Ban, T., Wang, Z., Choi, M. K., Kawamura, T., Negishi, H., Nakasato, M., Lu, Y., Hangai, S., Koshiba, R., Savitsky, D., Ronfani, L., Akira, S., Bianchi, M. E., Honda, K., Tamura, T., Kodama, T., and Taniguchi, T. (2009) HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. Nature 462, 99-103
36. Yang, H., Hreggvidsdottir, H. S., Palmblad, K., Wang, H., Ochani, M., Li, J., Lu, B., Chavan, S., Rosas-Ballina, M., Al-Abed, Y., Akira, S., Bierhaus, A., Erlandsson-Harris, H., Andersson, U., and Tracey, K. J. (2010) A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. Proc. Natl. Acad. Sci. U.S.A. 107, 11942-11947
37. Tang, D., Kang, R., Cheh, C. W., Livesey, K. M., Liang, X., Schapiro, N. E., Benschop, R., Sparvero, L. J., Amoscato, A. A., Tracey, K. J., Zeh, H. J., and Lotze, M. T. (2010) HMGB1 release and redox regulates autophagy and apoptosis in cancer cells. Oncogene 29, 5299-5310
38. Leclerc, E., Fritz, G., Vetter, S. W., and Heizmann, C. W. (2009) Binding of S100 proteins to RAGE: an update. Biochim. Biophys. Acta 1793, 993-1007